PT2376075E - Formulações nasais de metoclopramida - Google Patents

Formulações nasais de metoclopramida Download PDF

Info

Publication number
PT2376075E
PT2376075E PT98357965T PT09835796T PT2376075E PT 2376075 E PT2376075 E PT 2376075E PT 98357965 T PT98357965 T PT 98357965T PT 09835796 T PT09835796 T PT 09835796T PT 2376075 E PT2376075 E PT 2376075E
Authority
PT
Portugal
Prior art keywords
metoclopramide
nasal formulations
nasal
formulations
Prior art date
Application number
PT98357965T
Other languages
English (en)
Inventor
Matthew J D Onofrio
David A Gonyer
Shirish A Shah
Stuart J Madden
Original Assignee
Evoke Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42283402&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2376075(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evoke Pharma Inc filed Critical Evoke Pharma Inc
Publication of PT2376075E publication Critical patent/PT2376075E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98357965T 2008-12-22 2009-12-22 Formulações nasais de metoclopramida PT2376075E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14003408P 2008-12-22 2008-12-22

Publications (1)

Publication Number Publication Date
PT2376075E true PT2376075E (pt) 2015-06-08

Family

ID=42283402

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98357965T PT2376075E (pt) 2008-12-22 2009-12-22 Formulações nasais de metoclopramida

Country Status (8)

Country Link
US (1) US8334281B2 (pt)
EP (1) EP2376075B1 (pt)
CA (4) CA3155873C (pt)
DK (1) DK2376075T3 (pt)
ES (1) ES2536885T3 (pt)
PL (1) PL2376075T3 (pt)
PT (1) PT2376075E (pt)
WO (1) WO2010075444A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
PL2747561T3 (pl) * 2011-08-25 2018-11-30 Evoke Pharma, Inc. Leczenie objawów związanych z gastroparezą u osobników płci żeńskiej
WO2018112061A1 (en) * 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528310B2 (en) * 1978-11-16 1983-04-21 Beecham Group Plc Composition of paracetamol and metoclopramide
US4624965A (en) * 1984-11-15 1986-11-25 Nastech Pharmaceutical Co., Inc. Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
US4729997A (en) * 1985-10-15 1988-03-08 Nastech Pharmaceutical Co., Inc. Novel method of administering meclizine type pharmaceutical agents and novel dosage forms containing same
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
CH681690A5 (en) 1990-09-28 1993-05-14 Kali Chemie Pharma Gmbh New metoclopramide salt compsns. with no additives
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
US5760086A (en) * 1996-03-14 1998-06-02 Ribogene, Inc. Nasal administration of agents for treatment of delayed onset emesis
US5780431A (en) * 1996-09-20 1998-07-14 Neurobiological Technologies, Inc. Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
US6187332B1 (en) * 1999-06-14 2001-02-13 Wisconsin Alumni Research Foundation Acidic buffered nasal spray
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
US6433129B1 (en) * 2000-11-08 2002-08-13 Millennium Cell, Inc. Compositions and processes for synthesizing borohydride compounds
US6586563B1 (en) * 2001-12-18 2003-07-01 Millennium Cell, Inc. Processes for synthesizing alkali metal borohydride compounds
EP2123278B1 (en) 2007-02-07 2013-01-09 Teika Pharmaceutical Co., Ltd. Eye drop preparation comprising latanoprost

Also Published As

Publication number Publication date
EP2376075A2 (en) 2011-10-19
WO2010075444A2 (en) 2010-07-01
CA2780485C (en) 2017-12-12
CA3224872A1 (en) 2010-07-01
ES2536885T3 (es) 2015-05-29
CA2780485A1 (en) 2010-07-01
US8334281B2 (en) 2012-12-18
CA2984736C (en) 2022-07-05
DK2376075T3 (en) 2015-05-26
CA3155873A1 (en) 2010-07-01
EP2376075B1 (en) 2015-04-08
US20100163032A1 (en) 2010-07-01
PL2376075T3 (pl) 2015-08-31
CA3155873C (en) 2024-03-19
EP2376075A4 (en) 2012-05-30
WO2010075444A3 (en) 2010-11-04
CA2984736A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
HK1253355B (zh) 含有馬西替坦的治療組合物
ZA201200054B (en) Therapeutic compounds and compositions
GB2460523B (en) Improvements relating to respiratory interface devices
ZA201104495B (en) Conjugates of neurotensin or neurotensin analogs and uses thereof
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
GB0808835D0 (en) Therapeutic compositions
IL200013A0 (en) Indenoisoquinolinone analogs and methods of use thereof
IL211670A (en) Preparations containing therapeutic antibodies against steap-1
HK1160925A1 (zh) 組織蛋白酶 的用途
GB0806978D0 (en) Novel formulations
IL206577A0 (en) Formulations of flibanserin
HK1211207A1 (en) Improved medicinal aerosol formulations
GB0819958D0 (en) Therapeutic compositions
PT2376075E (pt) Formulações nasais de metoclopramida
EP2285776A4 (en) STABILIZATION OF TRIPHENYLBORE-PYRIDINE
HK1131039A1 (en) Pharmaceutical use of sophoricoside
IL189405A0 (en) Stabilization of siva2
EP2331490A4 (en) PREPARATION OF DIBUTOXYMETHANE
EP2282725A4 (en) NASAL FORMULATIONS OF INSULIN
AU330197S (en) Nasal cleanser
HU0800656D0 (en) Effective use of tea-composition
GB0813121D0 (en) Novel formulations